Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1871 1
1918 2
1919 1
1920 1
1924 1
1925 1
1928 1
1929 1
1933 1
1936 1
1938 4
1939 2
1943 3
1947 3
1948 9
1949 6
1950 13
1951 12
1952 24
1953 21
1954 13
1955 14
1956 12
1957 18
1958 14
1959 7
1960 7
1961 5
1962 3
1963 25
1964 60
1965 43
1966 20
1967 19
1968 31
1969 24
1970 23
1971 21
1972 24
1973 21
1974 25
1975 65
1976 73
1977 63
1978 72
1979 84
1980 105
1981 121
1982 105
1983 122
1984 132
1985 157
1986 148
1987 206
1988 206
1989 254
1990 268
1991 300
1992 327
1993 319
1994 385
1995 437
1996 463
1997 518
1998 563
1999 599
2000 703
2001 781
2002 781
2003 918
2004 987
2005 1198
2006 1291
2007 1305
2008 1343
2009 1480
2010 1634
2011 1826
2012 1938
2013 2293
2014 2568
2015 2947
2016 3195
2017 3420
2018 3606
2019 4210
2020 5005
2021 5799
2022 6012
2023 6021
2024 6861
2025 7963
2026 5570
2027 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79,996 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
The following terms were not found in PubMed: toconazole, /
Page 1
Showing results for toconazole/AE
Your search for TIOCONAZOLE/AE retrieved no results
Autoimmune Encephalitis Criteria in Clinical Practice.
Orozco E, Valencia-Sanchez C, Britton J, Dubey D, Flanagan EP, Lopez-Chiriboga AS, Zalewski N, Zekeridou A, Pittock SJ, McKeon A. Orozco E, et al. Neurol Clin Pract. 2023 Jun;13(3):e200151. doi: 10.1212/CPJ.0000000000200151. Epub 2023 Apr 25. Neurol Clin Pract. 2023. PMID: 37124463 Free PMC article.
BACKGROUND AND OBJECTIVES: To assess the clinical practice applicability of autoimmune encephalitis (AE) criteria (2016). METHODS: Medical records of 538 adults diagnosed with AE or related autoimmune encephalopathy at Mayo Clinic (not including pure movement disord …
BACKGROUND AND OBJECTIVES: To assess the clinical practice applicability of autoimmune encephalitis (AE) criteria (2016). METHODS: Me …
Mimics of Autoimmune Encephalitis: Validation of the 2016 Clinical Autoimmune Encephalitis Criteria.
Van Steenhoven RW, de Vries JM, Bruijstens AL, Paunovic M, Nagtzaam MM, Franken SC, Bastiaansen AE, De Bruijn MA, Van Sonderen A, Schreurs MWJ, Gardeniers M, Verdijk RM, Balvers RK, Sillevis Smitt PA, Neuteboom RF, Titulaer MJ. Van Steenhoven RW, et al. Neurol Neuroimmunol Neuroinflamm. 2023 Aug 15;10(6):e200148. doi: 10.1212/NXI.0000000000200148. Print 2023 Nov. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37582614 Free PMC article.
BACKGROUND AND OBJECTIVES: The clinical criteria for autoimmune encephalitis (AE) were proposed by Graus et al. in 2016. In this study, the AE criteria were validated in the real world, and common AE mimics were described. ...As expected, the specificity of t …
BACKGROUND AND OBJECTIVES: The clinical criteria for autoimmune encephalitis (AE) were proposed by Graus et al. in 2016. In this stud …
Acute exacerbation of idiopathic pulmonary fibrosis a narrative review primary focus on treatments.
Luo X, Xiang F. Luo X, et al. J Thorac Dis. 2024 Jul 30;16(7):4727-4741. doi: 10.21037/jtd-23-1565. Epub 2024 Jul 11. J Thorac Dis. 2024. PMID: 39144320 Free PMC article. Review.
However, the prevention and treatment of AE-IPF are still unclear. Based on the high mortality rate caused by AE, in this article, we will focus on the latest research advances in AE-IPF treatment strategies and provide a comprehensive review of its pathogene …
However, the prevention and treatment of AE-IPF are still unclear. Based on the high mortality rate caused by AE, in this arti …
AE 941.
[No authors listed] [No authors listed] Drugs R D. 2004;5(2):83-9. doi: 10.2165/00126839-200405020-00003. Drugs R D. 2004. PMID: 15293867 Review.
AE 941 [Arthrovas, Neoretna, Psovascar] is shark cartilage extract that inhibits angiogenesis. ...The agreement provides AEterna with upfront and milestone payments, as well as a return on manufacturing and sales of AE 941. AEterna Laboratories had granted Alcon Lab …
AE 941 [Arthrovas, Neoretna, Psovascar] is shark cartilage extract that inhibits angiogenesis. ...The agreement provides AEterna with …
Idiopathic Angioedema: Current Challenges.
Belbézier A, Bocquet A, Bouillet L. Belbézier A, et al. J Asthma Allergy. 2020 Apr 17;13:137-144. doi: 10.2147/JAA.S205709. eCollection 2020. J Asthma Allergy. 2020. PMID: 32368100 Free PMC article. Review.
The C1-inhibitor (C1-inh) functional assay can exclude AE due to C1-inh deficiency. Genetic diagnoses of hereditary AE due to abnormal C1-inh AE have progressed with four currently known mutations. However, determining the physiopathological mechanism leading …
The C1-inhibitor (C1-inh) functional assay can exclude AE due to C1-inh deficiency. Genetic diagnoses of hereditary AE due to …
Adsorption Energy in Oxygen Electrocatalysis.
Zhang J, Yang HB, Zhou D, Liu B. Zhang J, et al. Chem Rev. 2022 Dec 14;122(23):17028-17072. doi: 10.1021/acs.chemrev.1c01003. Epub 2022 Sep 22. Chem Rev. 2022. PMID: 36137296 Review.
Adsorption energy (AE) of reactive intermediate is currently the most important descriptor for electrochemical reactions (e.g., water electrolysis, hydrogen fuel cell, electrochemical nitrogen fixation, electrochemical carbon dioxide reduction, etc.), which can bridge the …
Adsorption energy (AE) of reactive intermediate is currently the most important descriptor for electrochemical reactions (e.g., water …
Pelvic angioembolization: how urgently needed?
Devaney GL, King KL, Balogh ZJ. Devaney GL, et al. Eur J Trauma Emerg Surg. 2022 Feb;48(1):329-334. doi: 10.1007/s00068-020-01510-1. Epub 2020 Oct 9. Eur J Trauma Emerg Surg. 2022. PMID: 33037465 Free PMC article.
We aimed to describe the patterns of AE use with hemostatic resuscitation and hypothesized that time to AE improved during the study period. ...Contemporary resuscitation challenges the need for hyperacute AE as no patients exsanguinated despite time to AE …
We aimed to describe the patterns of AE use with hemostatic resuscitation and hypothesized that time to AE improved during the …
SOP: antibody-associated autoimmune encephalitis.
Rössling R, Prüss H. Rössling R, et al. Neurol Res Pract. 2020 Jan 15;2:1. doi: 10.1186/s42466-019-0048-7. eCollection 2020. Neurol Res Pract. 2020. PMID: 33324907 Free PMC article.
RESULTS: The initial steps of the AE flow chart are based on clinical symptoms and the patient's history. Assignment to paraneoplastic or antibody-mediated AE is sometimes clinically possible. ...Classification of probable AE may be possible even with negativ …
RESULTS: The initial steps of the AE flow chart are based on clinical symptoms and the patient's history. Assignment to paraneoplasti …
Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
Kishaba T. Kishaba T. Eurasian J Med. 2017 Oct;49(3):204-206. doi: 10.5152/eurasianjmed.2017.17219. Eurasian J Med. 2017. PMID: 29123445 Free PMC article. Review.
However, IPF patients sometimes develop acute exacerbation (AE), which is a life-threatening condition. The cause of AE of IPF remains unknown. The new criteria for AE of IPF have been proposed last year, wherein both idiopathic and triggered AE were p …
However, IPF patients sometimes develop acute exacerbation (AE), which is a life-threatening condition. The cause of AE of IPF …
Clinical manifestations and prognostic factors analysis of patients hospitalised with acute exacerbation of idiopathic pulmonary fibrosis and other interstitial lung diseases.
Ba C, Wang H, Jiang C, Shi X, Jin J, Fang Q. Ba C, et al. BMJ Open Respir Res. 2024 Feb 27;11(1):e001997. doi: 10.1136/bmjresp-2023-001997. BMJ Open Respir Res. 2024. PMID: 38413119 Free PMC article.
Risk factors related to in-hospital mortality in patients with overall AE-ILD, AE-IPF and AE-non-IPF ILD were identified by multiple logistic regression analyses, respectively, and assessed by receiver operating characteristic curve. ...CONCLUSIONS: Clinical …
Risk factors related to in-hospital mortality in patients with overall AE-ILD, AE-IPF and AE-non-IPF ILD were identifie …
79,996 results
You have reached the last available page of results. Please see the User Guide for more information.